Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a supplement boost cancer immunotherapy? new study investigates urolithin a.

NCT ID NCT07161310

Recruiting now Knowledge-focused Sponsor: Goethe University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 29 times

Summary

This study tests whether a natural compound called urolithin A can improve the immune response in people with solid tumors (like lung cancer or melanoma) who are starting standard immunotherapy. About 45 adults will be randomly assigned to take either urolithin A or a placebo alongside their regular treatment. The main goal is to see if urolithin A changes the types of immune cells in the blood.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Universitätsklinikum Frankfurt, Medizinische Klinik II, Hämatologie/Onkologie

    RECRUITING

    Frankfurt, 60590, Germany

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.

MELANOMA NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER SOLID CANCER